| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Arcadia Biosciences (RKDA) | Credit Suisse/ J.P. Morgan/ Piper Jaffray | $86.26 | n.a. | |||
| Cellectis S.A. (CLLS) | BofA Merrill Lynch/ Jefferies/ Piper Jaffray | $115.00 | n.a. | |||
| eASIC Corporation (EASI) | Morgan Stanley/ Deutsche Bank Securities | $75.00 | n.a. | |||
| Jernigan Capital (JCAP) | Raymond James | $110.00 | n.a. | |||
| Philadelphia Energy (PESC) | BofA Merrill Lynch/ Credit Suisse | $100.00 | n.a. | |||
| SolarEdge Technologies (SEDG) | Goldman Sachs/ Deutsche Bank Securities | $125.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| AutoGenomics (AGMX) | Stifel/ Canaccord Genuity/ Cantor Fitzgerald | 10.00 | $10.00 | $10.00 | $100.00 | 1-Star |
| Infraredx (REDX) | RBC Capital Markets/ Canaccord Genuity/ BMO Capital Markets | 4.00 | $13.00 | $15.00 | $56.00 | 1-Star |
| Withdrawn | ||||||
| Advanced Accelerator Applications S.A (AAAP) | Citigroup/ Jefferies | 5.36 | $13.00 | $15.00 | $75.01 | 1-Star |
| Arysta LifeScience plc (ARYS) | Morgan Stanley/ J.P. Morgan | $100.00 | n.a. | |||
| New Terms | ||||||
| Black Knight Financial Services (BKFS) | J.P. Morgan/ BofA Merrill Lynch/ Wells Fargo Securities | $100.00 | n.a. | |||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Feb. 16, 2015 | Manager(s) | Offered | Raised | Price | 2/20/15 | Change |
| Check-Cap Ltd. (CHEKU) (u) | Chardan Capital Markets/ Maxim Group | 2.00 | $12.00 | $6.00 | $6.10 | 1.67% |
| Inotek Pharmaceuticals (ITEK) | Cowen and Company/ Piper Jaffray | 6.67 | $40.00 | $6.00 | $6.09 | 1.50% |
| (u) unit offering | ||||||